• Gossamer Bio Promotes Richard Aranda to CMO firstwordpharma
    June 22, 2021
    Gossamer Bio, Inc. (Nasdaq: GOSS) today announced that, Richard Aranda, M.D., previously Senior Vice President and Head of Clinical Development, will be promoted to Chief Medical Officer.
PharmaSources Customer Service